Shen X, Xia Y, Sass C, Visvikis S, Siest G
Shanghai Xin Hua Hospital, China.
Clin Chem Lab Med. 1998 Aug;36(8):615-9. doi: 10.1515/CCLM.1998.107.
The influence of apolipoprotein E polymorphism and apoE level on serum lipids and apolipoproteins was investigated in 71 healthy people and 43 patients with coronary artery disease from Shanghai. The frequency of apoE alleles was 0.06 for epsilon2, 0.86 for epsilon3, and 0.07 for epsilon4 in the healthy group, and 0.14 for epsilon2, 0.77 for epsilon3, and 0.09 for epsilon4 in the coronary artery disease group. There was no significant difference in the frequency of apoE alleles between these two groups. Serum levels of triglyceride and apo AI did not differ according to apoE genotypes, whereas serum level of apoB was significantly different according to apoE genotypes (p<0.05) both in healthy and coronary artery disease groups. However, in the healthy group, apo epsilon2 allele carriers had significantly higher level of apoE than apo epsilon3 and epsilon4 allele carriers (p<0.001) and apo epsilon4 allele carriers had significantly higher level of total cholesterol than apo epsilon3 and epsilon2 allele carriers. These were not observed in the coronary artery disease group. ApoE concentration was positively correlated with cholesterol, apoAI, and apoB levels in the control subjects and no significant correlation was observed with triglyceride level. In contrast, apoE level was positively related only to triglyceride level in the coronary artery disease group. In the control group, apoE genotypes and apoE level explained together 19.3% and 26.6% of the variability of apoB and cholesterol level, respectively, apoE polymorphism explained 23% of the variability of apoE level and apoE level explained 13.2% of the variability of apoAI level. In the coronary artery disease group, only apoE level explained 41.7% of triglyceride variability. Finally we compared our results with those previously obtained in a French healthy population, the Stanislas cohort. Results suggested that there were some difference between the Chinese control and the French subjects.
对来自上海的71名健康人和43名冠心病患者,研究了载脂蛋白E多态性和载脂蛋白E水平对血脂和载脂蛋白的影响。健康组中,ε2等位基因频率为0.06,ε3为0.86,ε4为0.07;冠心病组中,ε2等位基因频率为0.14,ε3为0.77,ε4为0.09。两组间载脂蛋白E等位基因频率无显著差异。无论在健康组还是冠心病组,甘油三酯和载脂蛋白AI的血清水平根据载脂蛋白E基因型并无差异,而载脂蛋白B的血清水平根据载脂蛋白E基因型有显著差异(p<0.05)。然而,在健康组中,ε2等位基因携带者的载脂蛋白E水平显著高于ε3和ε4等位基因携带者(p<0.001),且ε4等位基因携带者的总胆固醇水平显著高于ε3和ε2等位基因携带者。在冠心病组中未观察到这些情况。在对照组中,载脂蛋白E浓度与胆固醇、载脂蛋白AI和载脂蛋白B水平呈正相关,与甘油三酯水平无显著相关性。相比之下,在冠心病组中,载脂蛋白E水平仅与甘油三酯水平呈正相关。在对照组中,载脂蛋白E基因型和载脂蛋白E水平共同解释了载脂蛋白B和胆固醇水平变异性的19.3%和26.6%,载脂蛋白E多态性解释了载脂蛋白E水平变异性的23%,载脂蛋白E水平解释了载脂蛋白AI水平变异性的13.2%。在冠心病组中,只有载脂蛋白E水平解释了甘油三酯变异性的41.7%。最后,我们将我们的结果与之前在法国健康人群斯坦尼斯拉斯队列中获得的结果进行了比较。结果表明,中国对照组和法国受试者之间存在一些差异。